P142 Subcutaneously administered golimumab induction therapy improves health states measured by EQ-5D in patients with moderately to severely active ulcerative colitis: results from PURSUIT-SCPeter G. Gibson, W. Sandborn, Colleen Marano et al.|Journal of Crohn s and Colitis|2013Cited by 2